Affecting over 50 million people worldwide, around 80% of those living with epilepsy reside in low- and middle-income countries. Yet, epilepsy prevalence may still be underestimated due to limitations of the methodologies. https://neurotorium.org/slidedeck/epilepsy-epidemiology-and-burden/

There are three levels of diagnosis of epilepsy: Seizure type, Epilepsy type, and Epilepsy syndrome. Follow the link to read and download our expert-developed Epilepsy - History, Definitions & Diagnosis slide deck: https://neurotorium.org/slidedeck/epilepsy-history-definitions-and-diagnosis/

We're thrilled to announce Neurotorium's new educational theme on Epilepsy, featuring free, expert-developed educational resources designed for clinicians, students, educators, and anyone seeking reliable knowledge about this high-burden neurological condition. https://neurotorium.org/epilepsy/

Bipolar disorder (BD) is a chronic, recurrent mood disorder and leading cause of disability due to its impact on functioning and mortality. Our slide decks introduce BD’s varied symptoms, comorbidities, and treatment responses of individual patients. Explore more: https://neurotorium.org/bipolar/

The concept of the exposome - our physical and social environmental exposures across life - is reshaping how we understand health and disease. Read the latest Neurotorium article by Agustin Ibanez, PhD: https://neurotorium.org/article/the-physical-and-social-exposome-in-brain-health-and-dementia/

Did you know that Neurotorium's interactive 3D Brain Atlas is one of our most-visited tools? The 3D Brain Atlas offers a detailed 360° view of the human brain with high-resolution downloadable images for educational use. Explore the human brain: https://neurotorium.org/tool/brain-atlas/

New deck: Anxiety - Comorbidities. Comorbidity is common. Anxiety often co-occurs with other mental disorders and with medical illnesses - complicating diagnosis & treatment and highlighting the need for early, integrated care. https://neurotorium.org/slidedeck/anxiety-disorders-comorbidities/

New deck: Anxiety - Treatment Principles. Covers psychological & pharmacological therapies, disorder-specific CBT models, current pharmacologic options, predictors of response, combination strategies, and emerging treatments. https://neurotorium.org/slidedeck/anxiety-disorders-treatment-principles/

New deck: Anxiety - Neurobiology & Aetiology. From fear circuits to conditioning/extinction and biomarkers: what drives symptoms and why exposure works. Imaging, genetics, interoception, gut–brain, sex differences. https://neurotorium.org/slidedeck/anxiety-disorders-neurobiology-and-aetiology/

New deck: Anxiety - Course & Prognosis. Covers studies examining remission, relapse, and recurrence, as well as predictors of the course of anxiety. Explore here: https://neurotorium.org/slidedeck/anxiety-disorders-course-natural-history-and-prognosis/

New slide deck: Anxiety - Epidemiology & Burden. Covers recent research into prevalence rates of different anxiety disorders, comorbidities, as well as the individual and economic burden of anxiety disorders. Explore here: https://neurotorium.org/slidedeck/anxiety-disorders-epidemiology-and-burden/

New slide deck: Anxiety Disorders - History, Definitions & Diagnosis. Covers major manual updates, clinical features, staging, validated scales, and differential diagnosis. Explore here: https://neurotorium.org/slidedeck/anxiety-disorders-history-definitions-and-diagnosis/

Don't miss the newest Neurotorium article Brain Insulin Action and Metabolic Dysregulation in Schizophrenia: From Mechanistic Insights to Novel Interventions. https://neurotorium.org/article/brain-insulin-action-and-metabolic-dysregulation-in-schizophrenia/

Today is World Stroke Day. We believe stroke awareness and education are essential. With 1 in 4 people at risk, knowing the signs and acting fast can save lives. Visit https://neurotorium.org/stroke/ to access free educational resources and share the link to support stroke awareness #WorldStrokeDay

Virtual reality exposure therapy shows outcomes comparable to traditional in-vivo exposure, offering new opportunities for scalable, individualized anxiety treatments. Read the full overview on: 🔗 https://neurotorium.org/article/virtual-reality-in-anxiety-an-overview/ #AnxietyDisorders #VR

We’re live at #WASAD2025 in Munich! Come visit the Neurotorium booth to explore our brand-new Anxiety Disorders theme — free, expert-developed materials for clinicians, researchers & students. 🔗 neurotorium.org/anxiety

Anxiety disorders are now among the top 10 global health burdens - with prevalence rising by 50% over the past decade, affecting over 10% of the population. In this video, Prof. Brenda Penninx discusses what the data reveal. 🎥 Watch here: https://neurotorium.org/video/growing-burden-of-anxiety/

Neurotorium brought together world-leading experts from psychiatry and neurology for an extraordinary expert meeting on Advances in Cognition in Brain Disorders, held October 9-10, 2025, in Amsterdam. Thank you to all participating experts who made this unprecedented gathering exceptional.

We're excited to be attending the WASAD Congress next week in Munich, where we'll be showcasing our new Anxiety Disorders theme. Visit our booth to learn more about Neurotorium’s free expert-developed educational material! https://neurotorium.org/outreach/activities/

Many patients with anxiety disorders don’t respond fully to current drugs. New research highlights emerging treatments - from psychedelics to neuropeptide modulators - that may improve outcomes. Read more: https://neurotorium.org/article/emerging-pharmacological-treatments-for-anxiety-disorders/

10 October is World Mental Health Day - a reminder that there’s no health without mental health. Understanding how our brains work equips us to better support mental health. Every conversation about mental health benefits from scientific understanding. Explore https://neurotorium.org/themes/

What if you could ask your questions on bipolar disorder directly to experts? Join the Neurotorium's Campfire Session, “Precision medicine and measurement-based care in bipolar disorder,” at the 38th ECNP Congress on Sunday, 12 October, 13:55 CET. neurotorium.org/outreach/act... @ecnp.eu

Now live: our Anxiety theme - 6 expert-reviewed slide decks (200+ slides), 2 articles, 9 videos & 30+ figures. All free - no sign-up required. Explore here: neurotorium.org/anxiety/

🔝 Wir gratulieren herzlich: Gabriele Fischer von der #MedUniWien wurde in das Editorial Board von @neurotorium.org​ berufen! ⭕️ Ziel der Initiative: Bewusstsein & Wissen über das #Gehirn und seine Erkrankungen verbessern. Mehr erfahren! ⬇️

Treatment-resistant depression (TRD) represents a significant clinical challenge, affecting approximately 30% of individuals with major depressive disorder (MDD) who fail to respond to at least two adequate antidepressant trials. Read Neurotorium's article via: neurotorium.org/article/trea...

1 week to go! Next week we're launching our latest theme: Anxiety. Sign up to be the first to know about our free and open-access slide decks, articles, figures, and videos - all rigorously developed and reviewed by world-leading subject-matter experts. neurotorium.org/sign-up/ #anxiety

At Neurotorium, our mission is to improve awareness and knowledge of the brain and its diseases through freely accessible, expert-developed educational materials. Learn more: neurotorium.org/about/ @lundbeckfonden.bsky.social

World Alzheimer's Day is September 21. Alzheimer’s disease is the most common cause of dementia in people aged over 65, with ~55 million people living with dementia worldwide in 2020, which is projected to reach ~139 million by 2050. @alzassociation.bsky.social

Delirium is a medical condition characterized by the acute onset of deficits in attention and other aspects of cognition. Due to the complex network of predisposing and precipitating factors, it is often difficult to assign a specific cause of delirium in a patient. neurotorium.org/slidedeck/ne...

GBA1 links Gaucher disease & Parkinson’s. Increasing understanding of GBA1-driven PD pathology has led to promising treatment avenues, including use of virus vectors to deliver glucocerebrosidase to neurons, use of small molecule chaperone proteins, and more. neurotorium.org/image/gba1-f...

Don't miss Neurotorium's scientific session on 'Pathways to Precision Psychiatry' at the World Congress of Biological Psychiatry of the WFSBP in Berlin. Learn more neurotorium.org/outreach/act...

Emotional lability is thought to result from damage to descending brain pathways🧠 Such damage can occur in diseases, including #PD, #ALS, and as a result of #Stroke. Learn about post-stroke neuropsychiatric symptoms through our educational slide deck: neurotorium.org/slidedeck/ne...

Neurotorium is hosting a scientific session at the World Congress of Biological Psychiatry of the WFSBP, featuring four renowned experts who will discuss advances in precision psychiatry. Join our session in Berlin, and sign up for our monthly newsletter to stay updated: neurotorium.org/contact/

Did you know that you can download the illustrations at Neurotorium.org? Follow the link to explore our image database, where you can find 200+ illustrations about the brain and its diseases: neurotorium.org/image/

Traditional symptom-based diagnostic frameworks overlook the biological heterogeneity of psychiatric disorders. Immunopsychiatry, a leading example, is moving closer to defining and treating a more homogeneous subgroup within the broader depression spectrum. Read via neurotorium.org/article/prec...

The optimal outcome for a patient with MDD is a full recovery from the depressive episode and to never become depressed again. There is no universal treatment guideline for MDD – many evidence-based treatment guidelines have been developed. Learn more via neurotorium.org/slidedeck/ma...

Did you know that neuropsychiatric comorbidities occur in about 70% of people with MDD? Also, common physical comorbidities in MDD include cardiovascular, metabolic diseases, and others. Follow the link to learn more: neurotorium.org/slidedeck/ma...

Major Depressive Disorder (MDD) often has a remitting and relapsing course, and symptoms may persist between episodes. Read, download, and share our slide deck on MDD Course, natural history and prognosis neurotorium.org/slidedeck/ma...

What causes depression? Learn all about neurobiology and aetiology of MDD via our educational slide deck: neurotorium.org/slidedeck/ma... You can download the 30+ slides, all free, no sign-up required #depression #neurobiology #aetiology #educationalcontent

Depression is a burdensome condition. Across the world in 2021, it was responsible for 46 million DALYs, which can be seen as years of healthy life lost. The Epidemiology & Burden slide deck summarizes the global patterns and impact of the disease. Learn more: neurotorium.org/slidedeck/ma...

Depression is a broad and heterogeneous condition. Our slide deck on Definitions and Diagnosis introduces the fundamental concepts and definitions related to depression, including differential diagnosis and commonly used screening tools. Here: neurotorium.org/slidedeck/ma...

Neurotorium's theme on Depression has been comprehensively updated by the experts, including 6 expert-developed state-of-the-art educational slide decks, an expert-written article on precision psychiatry, and 25+ downloadable illustrations. All materials are free: neurotorium.org/depression/

Besides developing state-of-the-art and freely available educational materials about the brain, Neurotorium aims to facilitate dialogue and progress in neurology and psychiatry by organising scientific meetings, symposia, and other educational events. See here: neurotorium.org/outreach/act...

The application period for Neurotorium's Clinical Education Grant is coming to an end. Neurotorium is offering grants for projects that aim to enhance clinical training in neurology and psychiatry. Applicants worldwide are encouraged to submit proposals. Apply here: neurotorium.org/grants/clini...

Several Alzheimer’s Disease therapies target Aβ or its aggregates and can generally be divided into four therapeutic aims: reducing generation, enhancing degradation, neutralizing, or inhibiting aggregation. Learn more here: neurotorium.org/slidedeck/al...

Migraines can unfold over four distinct phases: prodrome, aura, headache, and postdrome. While the headache phase may last 4–72 hours in adults, most people reach peak pain within 1 hour. Learn more here: neurotorium.org/slidedeck/mi...

Bipolar disorder can develop through the interplay of biological, environmental, and mood-related risk factors. Early interventions offer hope for reducing the burden of this condition. Learn more here: neurotorium.org/slidedeck/bi...

Today marks the 12th WFN World Brain Day, with the theme: Brain Health for All Ages. Awareness of neurological and psychiatric disorders is critical. Find free, expert-reviewed resources for learning at Neurotorium.org: neurotorium.org #WBD2025

Approximately 80% of all strokes are ischaemic. The underlying pathology is often multifactorial, involving interrelated arterial and cardiac conditions. Identifying the specific cause of stroke is critical for both short-term and long-term care. Learn more here: neurotorium.org/slidedeck/ne...

We are offering grants for projects that aim to enhance training in neurology & psychiatry. This funding is open to applicants worldwide and is designed to support initiatives that contribute to medical training. Application deadline: 2nd September, 2025 Apply here: neurotorium.org/grants/clini...